Three-Dimensional Printing in Paediatrics: Innovative Technology for Manufacturing Patient-Centred Drug Delivery Systems
Pharmaceutics · 22.10.2025 · 17 (11) · 1364
DOI: 10.3390/pharmaceutics17111364 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 22.10.2025. Verfasst von Nadine Couți und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 41 V. Babes Stre…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romania Ministry of Research, Innovation and Digitization, CCCDI-UEFISCDI, Romania Ministry of Research, Innovation and Digitization, CCCDI—UEFISCDI.
Abstract (Originalsprache)
Additive manufacturing can be regarded as a game-changing approach for paediatric drug development, as children have special drug-related requirements which are rarely met by conventional technologies. Traditional dosage forms have considerable drawbacks, among them dose, excipient safety, and taste issues, which can be resolved by using three-dimensional (3D) printing. Ease of swallowing and an appealing design are among the improvements brought forth by 3D printing techniques. Techniques that have been thoroughly researched in the paediatric field include hot-melt extrusion (HME) coupled with fused deposition modelling (FDM), direct powder extrusion (DPE) and semisolid extrusion (SSE) 3D printing. Selective Laser Sintering (SLS) 3D bioprinting and binder-jet (BJ) 3D printing are other less known but highly useful techniques. A number of studies focus on significant subjects for the paediatric medicine domain, such as the acceptability of the produced formulations, the size of tablets, the design, the concealment of bitter API flavour, and the stability of the dosage forms. The 3D-printed oral formulations are varied: conventional-sized tablets, miniaturised tablets, chewable tablets, and orodispersible films or tablets. Most of the drugs used in the presented studies are essential medicines for children, for which commercial products with flexible doses and age-appropriate characteristics are often lacking. The practical implications of currently published studies and future directions for paediatric pharmaceutical 3D printing are described. Although there is a substantial amount of technical and in vitro data as well as paediatric engagement work on this subject, its translation into clinical practice is still limited. The clinical efficacy of 3D-printed dosage forms has to be further researched, since only a few studies have targeted this aspect.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania.
ORCID-Profile: Nadine Couți, Rareș Iovanov, Ioan Tomuță
Förderung
- Romania Ministry of Research, Innovation and Digitization, CCCDI-UEFISCDI
- Romania Ministry of Research, Innovation and Digitization, CCCDI—UEFISCDI
Zitieren
APA
Couți, N., Iurian, S., Porfire, A., Casian, T., Iovanov, R., & Tomuță, I. (2025). Three-Dimensional Printing in Paediatrics: Innovative Technology for Manufacturing Patient-Centred Drug Delivery Systems. Pharmaceutics, 17(11), 1364. https://doi.org/10.3390/pharmaceutics17111364
Vancouver
Couți N, Iurian S, Porfire A, Casian T, Iovanov R, Tomuță I. Three-Dimensional Printing in Paediatrics: Innovative Technology for Manufacturing Patient-Centred Drug Delivery Systems. Pharmaceutics. 2025;17(11):1364. doi:10.3390/pharmaceutics17111364
BibTeX
@article{Coui2025,
author = {Couți, Nadine and Iurian, Sonia and Porfire, Alina and Casian, Tibor and Iovanov, Rareș and Tomuță, Ioan},
title = {Three-Dimensional Printing in Paediatrics: Innovative Technology for Manufacturing Patient-Centred Drug Delivery Systems},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {11},
pages = {1364},
doi = {10.3390/pharmaceutics17111364}
}
EUVIMED